SCHEMBL7664079

SCHEMBL7664079

CSc1sccc1NS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.53
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
HSD11B1 P28845 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TDP1 Q9NUW8 2/20 0.48
GLO1 Q04760 1/20 0.48
PKM P14618 1/20 0.48
PKLR P30613 1/20 0.48
PLAU P00749 1/20 0.47
LMNA P02545 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
RAD52 P43351 1/20 0.46
POLB P06746 1/20 0.46
PGR P06401 1/20 0.45
PGAM1 P18669 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663530 0.83 ALDH1A1 (0.59) KMT2AMEN1GLO1PKMLMNA
SCHEMBL7248361 0.80 ALDH1A1 (0.49) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL7247948 0.79 ALDH1A1 (0.51) KMT2AMEN1L3MBTL1TDP1LMNA
SCHEMBL7673427 0.78 CCR2 (0.52) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL7663217 0.76 HCRTR1 (0.49) PGRPGAM1
SCHEMBL2747035 0.76 ACLY (0.62) KMT2AMEN1TDP1GLO1LMNA
SCHEMBL2748864 0.76 LMNA (0.71) ATMKMT2AMEN1L3MBTL1TDP1
SCHEMBL6928674 0.76 C1S (0.69) KMT2AMEN1PLAU
SCHEMBL7248655 0.74 SLC40A1 (0.45) L3MBTL1TDP1PKMALDH1A1
SCHEMBL7666030 0.74 C1S (0.43) KMT2AMEN1L3MBTL1PKMLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492403-B1 TREATING SYMPTOMS OF ACUTE OR CHRONIC DISORDER MEDIATED BY CLASSICAL PATHWAY OF COMPLEMENT CASCADE; PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-12-10 US disclosed